Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sage Therapeutics, Inc.    SAGE

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Sage Therapeutics : to Present at Goldman Sachs 41st Annual Global Healthcare Conference

share with twitter share with LinkedIn share with facebook
06/01/2020 | 06:32am EDT

Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020 at 3:00 p.m. ET.

A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.


© Business Wire 2020
share with twitter share with LinkedIn share with facebook
Latest news on SAGE THERAPEUTICS, INC.
06/10SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (f..
AQ
06/01SAGE THERAPEUTICS : to Present at Goldman Sachs 41st Annual Global Healthcare Co..
BU
05/11SAGE THERAPEUTICS : to Present at Bank of America Health Care Conference 2020
AQ
05/08SAGE THERAPEUTICS : to Present at Bank of America Health Care Conference 2020
BU
05/07SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Change ..
AQ
05/07SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
05/07SAGE THERAPEUTICS : Announces First Quarter 2020 Financial Results and Highlight..
BU
04/16SAGE THERAPEUTICS : to Report First Quarter 2020 Financial Results on Thursday, ..
BU
04/07SAGE THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Oth..
AQ
04/07SAGE THERAPEUTICS : Announces Restructuring to Advance Corporate Strategy and Pi..
BU
More news
Financials (USD)
Sales 2020 9,51 M - -
Net income 2020 -533 M - -
Net cash 2020 752 M - -
P/E ratio 2020 -4,13x
Yield 2020 -
Capitalization 2 178 M 2 178 M -
EV / Sales 2019
EV / Sales 2020 150x
Nbr of Employees 675
Free-Float 98,1%
Chart SAGE THERAPEUTICS, INC.
Duration : Period :
Sage Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SAGE THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 77,20 $
Last Close Price 41,96 $
Spread / Highest target 353%
Spread / Average Target 84,0%
Spread / Lowest Target -16,6%
EPS Revisions
Managers
NameTitle
Jeffrey M. Jonas President, Chief Executive Officer & Director
Kevin Paul Starr Chairman
Michael Cloonan Chief Operating Officer
Kimi E. Iguchi Chief Financial Officer & Treasurer
Albert J. Robichaud Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
SAGE THERAPEUTICS, INC.-41.88%2 178
LONZA GROUP48.64%41 432
CELLTRION, INC.70.44%34 546
SEATTLE GENETICS, INC.54.16%30 490
IQVIA HOLDINGS INC.-8.14%27 105
MODERNA, INC.212.32%23 753